pharmacopeia

Lutein

US-FDASourced from openFDA
GET
/api/v1/drug/lutein

Indications

Sourced from openFDA
  • STROVITE ® ONE is indicated to provide nutritional supplementation to support optimum vitamin and mineral levels.

Contraindications

Sourced from openFDA
  • STROVITE ® ONE is contraindicated in patients with hypersensitivity to any of its components. Folic Acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.contraindicated

Dosage & administration

Sourced from openFDA

One caplet daily or as directed by a physician.

Warnings & precautions

Sourced from openFDA

WARNING/PRECAUTIONS Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur. Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive. The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency. Avoid overdosage. Keep out of the reach of children.

Adverse reactions

Sourced from openFDA

Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in STROVITE ® ONE.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
37 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Emotional Distress719%
  2. 2Pain719%
  3. 3Anxiety616%
  4. 4Anhedonia514%
  5. 5Drug Ineffective514%
  6. 6Back Pain411%
  7. 7Dyspnoea411%
  8. 8Economic Problem411%
  9. 9Osteoporosis411%
  10. 10Alopecia38.1%
  11. 11Bone Density Decreased38.1%
  12. 12Chronic Kidney Disease38.1%
  13. 13Death38.1%
  14. 14Depression38.1%
  15. 15Dermatitis Atopic38.1%

Literature

View JSON

Recent PubMed references pinned to Lutein as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 140 ClinicalTrials.gov registrations naming Lutein as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

What is Lutein used for?
According to FDA labeling, Lutein carries indications including: STROVITE ® ONE is indicated to provide nutritional supplementation to support optimum vitamin and mineral levels.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What are the brand names for Lutein?
Lutein is marketed under brand names including Macuvite with Lutein, MaxiVision Lutein Formula, Ocuvite, Ocuvite Lutein, PreserVision with Lutein.
What are the contraindications for Lutein?
Lutein labeling lists contraindications including: STROVITE ® ONE is contraindicated in patients with hypersensitivity to any of its components. Folic Acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.. Always consult the full prescribing information and a clinician.
Note. Data for lutein is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients